ASX Share rice
Fri 14 May 2021 - 07:44:pm (Sydney)

COH Share Price

COCHLEAR LIMITEDCOHHealth Care Equipment & Services

COH Company Information

Name:

Cochlear Limited

Sector:

Healthcare

Industry:

Medical Devices

GIC Industry:

Health Care Equipment & Supplies

GIC Sub Industry:

Health Care Equipment

Address:

1 University Avenue Sydney NSW Australia 2109

Phone:

61 2 9428 6555

Full Time Employees:

4000

CEO, MD, Pres & Exec. Director:

Mr. Diggory William Howitt BE (Hons), MBA

Chief Technology Officer:

Mr. Jan Janssen

Pres of EMEA & Latin American Region:

Mr. Richard Brook

Pres of Americas Region:

Mr. Anthony Manna

Pres of Asia Pacific Region:

Mr. Anthony Bishop

CFO & Pres of Services:

Mr. Stuart Sayers

Chief Information Officer:

Mr. David Hackshall

VP of Investor Relations:

Ms. Kristina Devon

VP of Corp. Communications:

Ms. Jennifer Stevenson

Sr. VP of Global Marketing:

Mr. Dean Phizacklea

Company Overview:

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

COH Share Price Information

Shares Issued:

65.74M

Market Capitalisation:

$14.23B

Dividend per Share:

$1.15

Ex Dividend Date:

2021-03-25

Dividend Yield:

0.53%

Revenue (TTM):

$1.31B

Revenue Per Share (TTM):

$20.57

Earnings per Share:

$5.294

Profit Margin:

-0.1222

Operating Margin (TTM):

$0.17

Return On Assets (TTM):

$0.07

Return On Equity (TTM):

$-0.13

Quarterly Revenue Growth (YOY):

-0.017

Gross Profit(TTM):

$0.96B

Diluted Earnings Per Share (TTM):

$-2.513

QuarterlyEarnings Growth(YOY):

0.317

COH CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-379,200,000

Change To Liabilities:

$-65,000,000

Total Cashflow From Investing Activities:

$-509,700,000

Net Borrowings:

$266.30M

Net Income:

$-238,300,000

Total Cash From Operating Activities:

$-157,800,000

Depreciation:

$66.70M

Other Cashflow From Investing Activities:

$-379,200,000

Dividends Paid:

$-193,700,000

Change To Inventory:

$-28,400,000

Change To Account Receivables:

$82.50M

Sale Purchase Of Stock:

$1.08B

Capital Expenditures:

$92.90M

COH Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-271,100,000

Net Income:

$-238,300,000

Gross Profit:

$0.98B

Operating Income:

$-262,200,000

Other Operating Expenses:

$-5,500,000

Interest Expense:

$-1,700,000

Income Tax Expense:

$-32,800,000

Total Revenue:

$1.32B

Cost Of Revenue:

$336.20M

COH Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$139.40M

Total Liabilities:

$1.17B

Total Stockholder Equity:

$1.40B

Other Current Liabilities:

$184.70M

Total Assets:

$2.58B

Common Stock:

$1.27B

Other Current Assets:

$1.20M

Retained Earnings:

$116.40M

Other Liabilities:

$71.30M

Good Will:

$270.90M

Other Assets:

$212.30M

Cash:

$565M

Total Current Liabilities:

$817.50M

Property - Plant & Equipment:

$438.80M

Net Tangible Assets:

$1.05B

Long-Term Investments:

$94.90M

Total Current Assets:

$1.48B

Long-Term Debt:

$79.90M

Net Receivables:

$304.90M

Short-Term Investments:

$1.10B

Inventory:

$223.80M

Accounts Payable:

$159.30M

Short-Term Investments:

$1.10

Non Current Liabilities Total:

$356.70M

COH Share Price History

COH News

03 May, 2021
Adults with cochlear implants may be able to improve their listening and communications skills in daily life with the help of a new self-guided digital tool by Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions.
02 May, 2021
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
01 Apr, 2021
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
08 Mar, 2021
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces the U.S. Food and Drug Administration (FDA) clearance of the new Cochlear™ Baha® 6 Max Sound Processor, designed to improve hearing outcomes for people with SSD (single-sided deafness), conductive or mixed hearing loss.
03 Mar, 2021
Cochlear has joined people with hearing loss, hearing care experts and advocates in welcoming the World Health Organization's (WHO) landmark World Report on Hearing, which calls upon governments and societies to prioritize hearing health.
02 Mar, 2021
Investors who take an interest in Cochlear Limited ( ASX:COH ) should definitely note that the Independent...
20 Feb, 2021
Cochlear Limited ( ASX:COH ) just released its interim report and things are looking bullish. It was overall a positive...
12 Feb, 2021
How far off is Cochlear Limited ( ASX:COH ) from its intrinsic value? Using the most recent financial data, we'll take...
03 Feb, 2021
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today the winners of the 19th annual Graeme Clark and the 10th annual Anders Tjellström Scholarships. The scholarships, named after two pioneers of the hearing implant industry, recognize Cochlear™ Nucleus® Implant, Cochlear Baha® System and Cochlear Osia® System recipients in the United States and Canada who uphold the Cochlear ideals of leadership, humanity, and demonstrate high academic achievement. The scholarships are to enable Cochlear recipients to further accomplish their goals through education.
26 Jan, 2021
Ninety-five percent of people living with hearing loss in the United States say masks and facial coverings impact their ability to communicate during the COVID-19 pandemic, which has also heightened levels of anxiety, social isolation and other mental health-related effects among nearly half of the nation's hearing loss community.1
13 Jan, 2021
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
14 Dec, 2020
If you want to know who really controls Cochlear Limited ( ASX:COH ), then you'll have to look at the makeup of its...
18 Nov, 2020
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side...
09 Sep, 2020
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, is encouraging adults with hearing loss to utilize the Cochlear Hearing Aid Check, a new, free online tool that launches broadly this Healthy Aging Month. The tool allows adults with hearing aids who are struggling to hear to learn if they may benefit from a cochlear implant. The tool aims to help participants, particularly in the aging adult population, compare their hearing performance with hearing aids to people with a cochlear implant, and depending on their results, to seek further hearing healthcare advice to treat their loss.
22 Jul, 2020
Australian shares closed lower on Wednesday, dragged down by the healthcare sector, as a record surge in COVID-19 cases in the country dented investor sentiment. Australia recorded 501 new coronavirus infections in the past 24 hours, its highest since the epidemic took hold in March, with Victoria state, of which Melbourne is the capital, accounting for almost 97% of the new cases. "The fact that metro Melbourne, which is about 5 million people, has already been in a lockdown for the last couple of weeks and still not seeing a drop in cases is probably something to be a little concerned about," said Steven Daghlian, market analyst at CommSec.
16 Jul, 2020
With a price-to-earnings (or "P/E") ratio of 36x Cochlear Limited (ASX:COH) may be sending very bearish signals at the...
06 Jul, 2020
Cochlear Limited (ASX:COH), the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration (FDA) approval of three new products to its suite of hearing technology solutions. The approval of the Cochlear™ Nucleus® Kanso® 2 Sound Processor, Nucleus® 7 Sound Processor for Nucleus 22 Implant recipients and Custom Sound® Pro fitting software reflects Cochlear's ongoing commitment to innovation in hearing technology, providing access to smartphone connectivity and helping to improve hearing performance, and enhancing the cochlear implant fitting experience for hearing health professionals.
16 Jun, 2020
Cochlear's's (ASX:COH) stock is up by a considerable 13% over the past three months. Given the company's impressive...
19 May, 2020
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval on March 17 to lower the age of cochlear implantation from 12 months to 9 months for children with bilateral, profound sensorineural hearing loss. This important approval ensures children born deaf have earlier access to a cochlear implant which can provide them with the hearing capabilities to develop speech and language at a trajectory similar to their hearing peers. Ensuring children have access to sound as early as possible should be prioritized as surgeries begin resuming across the country due to the COVID-19 pandemic.

COH Dividend Payments

EX-Date Dividend Amount
2010-02-22$0.9500
2010-08-27$1.0500
2011-02-21$1.0500
2011-08-26$1.2000
2012-02-22$1.2000
2012-08-24$1.2500
2013-02-21$1.2500
2013-03-21$0.5000
2013-08-23$1.2700
2014-02-28$1.2700
2014-09-02$1.2700
2015-03-03$0.9000
2015-09-08$1.0000
2016-03-10$1.1000
2016-09-07$1.2000
2017-03-15$1.3000
2017-09-19$1.4000
2018-03-19$1.4000
2018-09-17$1.6000
2019-03-25$1.5500
2019-09-19$1.7500
2020-03-24$1.6000
2021-03-25$1.1500

COH Dividends (last 12 Years)